COVID-19 Pandemic
2020
Timeline of significant global, Australian and SA data points in the initial response and first year of the COVID-19 Pandemic.

Navigate the timeline pages:
1800s | 1900-1945 | 1946-1979 | 1980-1999 | 2000-2015 | 2016-2018 | 2019 | You Are Here | 2021 | 2022 | 2023 | 2024 | 2025
Quick links to months of 2020:
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sept | Oct | Nov | DecGive the page a couple of moments to load…it is long. Some of the links may not work due to the length! Best viewed on a large screen.

Moderna: COVID-19 vaccine has 94.5% efficacy
In a press release on November 16, 2020, Moderna announced their intended to submission to the FDA for Emergency Use Authorisation of their COVID-19 vaccine, on the back of their Phase 3 trial returning 94.5% efficacy. [1]
A fuller analysis was released on November 30, 2020, which showed a 94.1% efficacy.
Danish RCT mask study concludes no statistical difference
Published: Danish randomised controlled trial (RCT) (originally 18 Nov 2020) looking specifically at the effectiveness of wearing surgical masks to protect against SARS-CoV-2 infection.
“Our results suggests that the recommendation to wear a surgical mask when outside the home among others did not reduce, at conventional levels of statistical significance, the incidence of SARS-CoV-2 infection in mask wearers.” [1]
In the October 2019 WHO non-pharmaceutical measures report for Influenza, they too concluded that masks were not recommended for healthy people. [2]
Additional mask info found >> AAPS, HART, OSHA, Dr Rancourt [2], SPR
Yet the health authorities of the world continue to make their people wear masks even in light of the science.
Pfizer-BioNTech announce their vaccine is 95% effective
In a press release on November 9, 2020, Pfizer-BioNTech announce their preliminary phase 3 clinical trial data suggests their COVID-19 vaccine is more than 90% effective. [1, 2]
Then they announced via press release on November 18, 2020, that the final analysis of their COVID-19 vaccine Phase III clinical trial data showed it was 95% effective and with no safety concerns, stating:
“Primary efficacy analysis demonstrates BNT162b2 to be 95% effective against COVID-19 beginning 28 days after the first dose;170 confirmed cases of COVID-19 were evaluated, with 162 observed in the placebo group versus 8 in the vaccine group”.
“Efficacy was consistent across age, race and ethnicity demographics. The observed efficacy in adults over 65 years of age was over 94%,” [1]
Those results had yet to be peer reviewed, but the media ran with the claim. Pfizer filed for emergency use authorization with the FDA “within days” of this announcement.
South Australia goes into Lockdown
State Coordinator, Commissioner Grantley Stevens enacted a Stay at Home Direction to lockdown a million South Australians for a 6 days “circuit breaker” on the back of an alleged new “pizza box” transmission as claimed by Chief Public Health Officer Professor Spurrier. [1, 2, 3]
The Direction was revoked on 22nd November, 3 days later, allowing South Australians out of home lockdown.
FDA publishes Emergency Use Authorization (EUA) explanation
On November 20, 2020 the US Food and Drug Administration (FDA) published a webpage to explain how Emergency Use Authorization (EUA) , a regulatory mechanism to them during public health emergencies.
Under an EUA, FDA may allow the use of unapproved medical products, or unapproved uses of approved medical products in an emergency to diagnose, treat, or prevent serious or life-threatening diseases or conditions when certain statutory criteria have been met, including that there are no adequate, approved, and available alternatives.
They reiterated the FDA is “globally respected” as a regulator and are trusted by the public, insinuating their authorisation means a “rigorous” evaluation has been made.
WHO advises against remdesivir in COVID-19 patients
On November 20, 2020, the World Health Organisation (WHO) issued a conditional recommendation against the use of remdesivir in hospitalized patients, regardless of disease severity, as there is “currently” no evidence that remdesivir improves survival and other outcomes in these patients. [1, 2]
Study: asymptomatic cases NOT the driver of SARS-CoV-2 spread
A study published November 20, 2020 of a city-wide, 19 day, mass PCR screening programme of nearly 10 million residents in Wuhan, China in the post-lockdown period from May 14, 2020 (Alpha variant), shows there “were no positive tests amongst 1,174 close contacts of [the 300] asymptomatic cases.”
Meaning those who have no symptoms but return a positive PCR result (asymptomatic) did not spread virus to close contacts.
Wuhan was under strict lockdown measures from January 23, 2020 until April 8, 2020. Lockdown was used to stop the virus spread, but mostly because “on of China’s top expert” there were “super spreaders“. Following lockdown, “the COVID-19 epidemic was generally under control in China, and the whole country has progressed into a post-lockdown phase.”
A systematic review published December 2020 showed asymptomatic spread was not a driver of the pandemic. [2]
In May 2022 published a systematic review of nearly 30,000 people over 42 countries has found asymptomatic carriers are about 68% less likely to pass the virus on compared to those with symptoms. [1]
The “symptoms” that can be classified as COVID-19 have undergone several changes over the course of the pandemic, initially being “a high temperature, a cough and a loss of taste or smell, but then simply feeling tired and a headache were added. So a healthy person with a headache that returns a [false] positive PCR result can be labelled “statistically sick” with COVID-19 i.e. a “case”. The more you “tests” the more “cases” will be found.
The risk of asymptomatic spread of SARS-CoV-2 was/is the reason governments around the world pushed for the testing and lockdown of healthy people. Quarantine of the sick has traditionally been the public health measure.
Vaxxed vs Unvaxxed children’s health study published
Published: “A retrospective analysis spanning ten years of pediatric practice focused on patients with variable vaccination born into a practice, presenting a unique opportunity” to study the health outcomes of vaccinated children versus unvaccinated.
“The implications of these results for the net public health effects of whole-population vaccination and with respect for informed consent on human health are compelling.”
The CDC has never done such a health outcome study – see July above.
CDC publish baseline mRNA COVID-19 vaccine information – vaccine stays in the arm muscle, and spike is “harmless”
On November 23, 2020 the US CDC published information on the expected to be authorised new technology mRNA COVID-19 vaccines. [1, 2]
Stating “facts” that emerging science showed, turned out to be misinformation.
- The “immune response” that “produces antibodies, is what protects us from getting infected if the real virus enters our bodies”.
- The protein which the COVID-19 mRNA vaccines instructs the human cells to make was advertised as “a harmless piece of what is called the “spike protein.””
- The “vaccines are given in the upper arm muscle. Once the instructions (mRNA) are inside the muscle cells, the cells use them to make the protein piece. After the protein piece is made, the cell breaks down the instructions and gets rid of them.” Which the media then spread the world, quoting CDC. [5] – It was soon discovered the LNP carrying mRNA dosnt stay in the arm.
- “At the end of the process, our bodies have learned how to protect against future infection. The benefit of mRNA vaccines, like all vaccines, is those vaccinated gain this protection without ever having to risk the serious consequences of getting sick with COVID-19.”
- “mRNA never enters the nucleus of the cell, which is where our DNA (genetic material) is kept.” – (No evidence to support this statement) [3]
- “mRNA COVID-19 vaccines cannot give someone COVID-19″ – [COVID-19 is a collection of symptoms, the SARS-CoV-2 spike protein is demonstrating to cause COVID-19 like symptoms]
The only COVID-19 vaccines theFDA will grant emergency use authorization are those that meet the ” rigorous safety and effectiveness standards” guidelines, of amongst other things, >50% with placebo controlled trials.
Researchers have been studying and working with mRNA vaccines “for decades” even though there “are currently no licensed mRNA vaccines”.
“Interest has grown in these vaccines because they can be developed in a laboratory using readily available materials. This means the process can be standardized and scaled up, making [ALL] vaccine development faster than traditional methods of making vaccines.”
“Future mRNA vaccine technology may allow for one vaccine to provide protection for multiple diseases, thus decreasing the number of shots needed for protection against common vaccine-preventable diseases.”
The CDC later quitely removed from website, their claim that the “mRNA and the spike protein do not last long in the body”, which follows is later edited after the science shows it can remain in blood for at least 28 days, let alone the arm muscle.
TGA assure rigorous assessment before COVID-19 vaccines approved
On November 27, 2020 Australia’s Therapeutics Goods Administration (TGA) state on their website that they “will rigorously assess any COVID-19 vaccine for safety, quality and effectiveness before it can be supplied in Australia.”
On March 29, 2018 the Therapeutics Goods Act 1989 was amended to include a Provisional Registration clause to allow products to enter the system on limited data, not allowed for normal registration. The clause was sold on the intent of providing life-saving medication to cancer patinets, and to have our regulatory system was in line with the rest of the world – with a fast-track, emergency-like provision!
PCR tests flawed – excessive false positives
On November 27, 2020, twenty-two international consortium scientists submitted a request to retract the Drosten paper from the journal Eurosurveillance due to fatal flaws and conflicts of interest. Upon reviewing the paper the came to a damning verdict: the study contains nine serious scientific errors and three minor inaccuracies. Such as:
- The primer design is inadequate
- The binding temperature used is too high, allowing for non-specific binding
- Th enumber of cycles in paper is 45; greater than 30 is known to be problematic
- no positive or negative controls were performed
- There is a risk of false positive results due to the imprecise test design
- Two of the authors (Prof. Drosten and Chantal Reusken) are members of the editorial board of Eurosurveillance!
This external peer review analysis of the Drosten-led pivotal PCR paper, revealed that the PCR test protocol used worldwide as the “gold standard” for “diagnosing” COVID-19, is likely producing excessive false positives, which “has led to worldwide misdiagnosis of infections attributed to SARS-CoV-2 and associated with the disease COVID-19.” The exaggerated PCR-driven case numbers led to a “casedemic”. [2, 4]
Among the reviewers is geneticist Kevin McKernan, the main initiator of the Human Genome Project, who holds several patents in the field of PCR diagnostics. [5]
A few weeks later, on December 14, 2020, the WHO acknowledges this PCR cycle threshold testing flaw, just as vaccines are about to be rolled out. [3]
Watch >>>
Doctors petition EMA to stop vax trials – serous concerns
On December 1, 2020 the International Consortium of Scientists in Life Sciences (ICSLS), led by ex-Pfizer scientists Dr Michael Yeadon and German public health expert Dr Wolfgang Wodarg, filed an application with the European Medicine Agency (EMA), the body responsible for EU-wide drug approval, requesting the immediate suspension of all SARS-CoV-2 vaccine studies. [1]
In their 43 page document they lay out their reasons for the urgent request to halt the trials, which include:
- Possible Infertility issues: Syncytin-1 is a prerequisite for a successful human pregnancy and is also found in “homologous form in the spike proteins of SARS viruses”, it could be possible anti-spike antibodies could also act as anti-Syncytin-1 antibodies thus a vaccinated woman could be rendered infertile for an unknown duration.
- Likely ADE: The formation of “non-neutralising antibodies” could lead to an exaggerated immune reaction, known as antibody-dependent enhancement (ADE) phenomenon; when a vaccinated person is exposed to a “wild” coronavirus they could die, as was demonstrated in animal studies. The vaccine induced “immune response” rendered them vulnerable when re-infected
- PEG anaphylaxis: The mRNA vaccines contain polyethylene glycol (PEG) which 70% of people develop antibodies against, as such exposing them to potentially fatal allergic reactions upon vaccination.
- Unknown long-term side effects: It simply can not be determined what long term health issues could result when only short-term clinical trials are conducted, as was the case with narcolepsy experienced post-2009 swine flu vaccination, thus an emergency approval could expose an unsuspecting population of hundreds of millions of people to unacceptable risks.
Pfizer documents show they knew their vaccine had limited efficacy
For first 3 months post FDA authorization Pfizer received multiple reports of both vaccine failure and vaccine ineffectiveness according to FOIA documents.
Pfizer’s internal documents that were released by court order in 2022 under FOIA revealed that beginning on December 1, 2020, Pfizer was aware by February 28, 2021 that their vaccine had limited efficacy and that 136 people died following injection!
UK the first country to authorise a COVID-19 vaccine
On December 2, 2020, the Pfizer-BioNTech COVID-19 vaccine was “temporarily authorised“, by UK’s Medicines and Healthcare products Regulatory Agency ( MHRA), becoming the first COVID-19 vaccine to be authorised anywhere in the world, “paving the way for mass vaccination”. [1, 2]
The vaccine was reported to offer “up to 95% protection against Covid-19 illness”. Pfizer’s CEO stated on December 3, 2020 that Pfizer don’t know if the vaccine will prevent transmission – the entire purpose of a mass vaccination campaign.
The governments authorisation “follows months of rigorous clinical trials and a thorough analysis of the data by experts at the MHRA who have concluded that the vaccine has met its strict standards of safety, quality and effectiveness”, contradictory to Pfizer FOIA documents.
On 30 December “the cheaper and easier-to-distribute Oxford-AstraZeneca COVID-19 vaccine” was approved. A third vaccine, produced by Moderna, was approved for use in the UK in January 2021. Finally, Janssen’s single-dose vaccine was approved in May 2021, although it is yet to be used. [1, 2]
Florida mandates testing labs report PCR “cycle threshold values”
On December 3, 2020, the US state of Florida, headed by Governor Ron deSantis, mandated that all COVID-19 testing labs to report the “cycle threshold values” for every PCR test they perform – in an attempt to rule out the high rate of false positive results. [1, 2]
Governor deSantis is guided by Florida’s Surgeon General Dr Joseph Ladapo, who is trained in public health and is following the scientific evidence.
Reporting cycle number (Ct value) for a quantitative PCR (qPCR) diagnostic test, that is the number of amplifications needed to return a “fluorescence” reading for the sample in an automated thermal cycler, was a standard procedure for pathology labs prior to COVID-19 pandemic. The lower the Ct number the more confident a clinician can be they got their diagnosis is correct. For other diseases such as pertussis ≥ 35 is classified as “indeterminate”, and tests should not be used alone.
US COVID-19 vaccination cards released
The US Department of Defense (DoD) released the first images of a COVID-19 vaccination record card and vaccination kits on December 3, 2020, prior to anticipated EUA of COVID-19 vaccines. [3]
“Vaccination cards will be used as the “simplest” way to keep track of Covid-19 shots, said Dr. Kelly Moore, associate director of the Immunization Action Coalition, which is supporting frontline workers who will administer Covid-19 vaccinations.” [1, 2]
The 100 million DoD vaccine kits “include a card, a needle and syringe, alcohol wipes and a mask. Operation Wa
The card for the 2-shot vaccines already has additional spaces for 2 booster shots – as though it was planned! The vaccination clinics are to also report the data electronically to their state immunization registries and the CDC – making a card redunant unless they planned ahead of time to use it as “proof of vaccination” to be eligible to move in society
Pfizer CEO ‘not certain’ if their vaccine will prevent transmission
On December 3, 2020, just one day after the UK became the first country to grant emergency use authorisation for Pfizer-BioNTech’s COVID-19 vaccine, it was reported that Pfizer’s CEO Albert Bourla said in an interview with NBC that the company is “not certain” if their vaccine will prevent transmission, “I think this is something that needs to be examined” he said. [1, 2]
WHO finally acknowledges PCR test flaw
On December 14, 2020, the World Health Organization (WHO) released a guidance memo (dated December 7, 2020), warning that high cycles on PCR tests could result in false positives. [1]
During the pandemic positive PCR is a positive “diagnosis” for COVID-19, rendering the person a COVID-19 “case” when in fact the asymptomatic person is highly likely negative, because HIGH CYCLES of 40-45 have been used throughout 2020 to create large number of false cases.
Traditionally PCR tests are use as a confirmatory test to help a doctor determine a disease diagnosis in someone who has symptoms.
But from March 2020 when the WHO declared “test, test, test”, millions of people who were designated a “close contact” received a test whether they had symptoms or not. If the PCR test returned a positive result, they were diagnosed as having COVID-19 (the disease), labelled asymptomatic if they were healthy, and became a “case” statistic. If the test was amplified over 35 cycles, 97% of “positive” results would be a “false positive“. PCR cycling was commonly run up to 40 to 45 cycles! Australia up to 40 cycles.
A few weeks before, on November 27, 2020 the European consortium of scientists requested the pivotal PCR test publication be retracted.
First COVID-19 vaccine administered in UK, which is the first western country to rollout the vaccine
As planned, on 7 December, 2020 the UK is the first western country to roll out it’s emergency use COVID-19 vaccine, of which 90 year old Margaret Keenan publicly received the first dose of Pfizer-BioNTech COVID-19 vaccine (she gets second dose on Dec 30) and William Shakespeare was the first man to receive the vaccine outside of clinical trials. [1]
“On 2 December 2020, the Pfizer-BioNTech Covid-19 vaccine was approved for use in the UK, becoming the first to be authorised anywhere in the world. This was followed on 30 December by the cheaper and easier-to-distribute Oxford-AstraZeneca vaccine.” [2]
The US administered their first COVID-19 vaccine on December 14, 2020
Hacked EMA data reveals potential significant CV19 mRNA batch integrity issues
On December 9, 2020 the European Medical Agency (EMA) was the subject of a cyberattack which was revealed that “COVID-19 medicines and vaccines” [1] data was stolen. This included “email screenshots, EMA peer review comments, Word documents, PDFs, and PowerPoint presentations”, of which some of those documents related to “the regulatory submission for Pfizer and BioNTech’s COVID-19 vaccine candidate, BNT162b2.” [2]
Nineteen days after the hack, on December 21, 2020, the EMA granted Conditional Marketing Authorization (CMA) to Pfizer-BioNTech, for the very vaccine in question – which the hack reveals that the EMA regulators had at the time over 100 regulatory objections.
On of the biggest objection was reported by a BMJ investigation published on March 10, 2021, that revealed by November 23, 2020 the EMA “regulators had major concerns over unexpectedly low quantities of intact mRNA” …”between the clinical batches and proposed commercial batches—from around 78% to 55%.” Revealing concerning batch integrity instability. [3, 4, 5, 6]
CDC launches V-Safe App to track COVID-19 vaccine side effects
On December 10, 2020 the CDC launched their new COVID-19 vaccine smartphone App called V-safe After Vaccination Health Checker. Volunteers could download the app and then be prompted to report any “side effects” they experience following their COVID-19 vaccinations. “Depending on your answers, someone from CDC may call to check on you and get more information. And v-safe will remind you to get your second COVID-19 vaccine dose if you need one.” [1] The app prompts feedback on days 21 and 42 after each vaccine dose and at 3, 6, and 12 months after the last vaccine dose. [5]
Initially, on Jan 28, 2021, the CDC planned to call anyone who reported an adverse health impact to v-safe (v-safe protocol v.2 at p.5) but by May 20, 2021 they “had to abandon that plan early on after rolling out v-safe due to the volume of people reporting impacts (v-safe protocol v.3 at pp.7-8)” [6] They also didn’t include their proposed Adverse Events of Special Interest (AESI) as check boxes.
On December 29, 2020 the CDC decided to set up the V-Safe Pregnancy surveillance protocol which would look for pregnant women and ask them to join the v-safe pregnancy registry. It was based on data from this registry that the CDC first recommended the CV19 jabs to “pregnant persons” on April 23, 2021. [2, 3]
As this is public information, and the CDC promised transparency, ICAN through it’s lawyer Aaron Siri, FOIA’d the CDC for all the v-safe data. Following 464 Days of trying and ultimate having to sue the CDC in court, the check box info [7] from over 10 million users was released under court order on September 30, 2022 and then not until February 15, 2024 also under court order , the 7.8 million “free text” field data will be released. [4]
- ICAN V-Safe FOIA data – HERE
V-safe has now been expanded to include other vaccines.
Australia cancels 51 million doses of Uni QLD vaccine due to HIV scare
Australian government drops Uni Qld, CSL, CEPI COVD-19 vaccine after volunteers in early clinical trials “falsely” tested positive for HIV. A pre-order for 51 million vaccine doses was cancelled. $750 million investment. Trials began on July 13, 2020 with the involvement of CSIRO.
Health Minister Greg Hunt said that while the HIV test results were false, “the scientific advice is that the risk to vaccine confidence was the principal issue here.” [1]
This vaccine generates antibodies for the “Molecluar Clamp” that is “critical for driving membrane fusion and cell entry”. The HIV-1 coat protein – GP41 is known to be neurotoxic. [2]
FDA issues first COVID-19 vaccine EUA for Pfizer-BioNTech with no data on “preventing transmission”
On December 11, 2020, the US Food and Drug Administration (FDA) granted the first Emergency Use Authorisation (EUA) for a brand new technology product, the Pfizer-BioNTech COVID-19 mRNA vaccine, just 9 months after phase I trials began, and after only 108 days of regulatory safety review. In their press release they stated: “The FDA has determined that Pfizer-BioNTech COVID-19 Vaccine has met the statutory criteria for issuance of an EUA”. The FDA stated the vaccine “may be effective in preventing COVID-19″, then state it is 95% effective in “preventing” COVID-19, that 95% is based on “a 2 month study of a couple hundred people. That’s it!“. [3]
The day before, on December 10, 2020, the Vaccines and Related Biological Products Advisory Committee (VRBPAC) met to assess the Pfizer-BioNTech COVID-19 Vaccine and prepare a Briefing Document for the FDA. [6]
The FDA stated “[t]he vaccine was 95% effective in preventing COVID-19 disease among these clinical trial participants with eight COVID-19 cases in the vaccine group and 162 in the placebo group.” 8 plus 162 equals 170 trial participants was all that were used to determined the relative risk of “95% effective”, where as the absolute risk (of all 36,523 trial participants) works out to less than 1% effective. [4]
“At this time, data are not available to make a determination about how long the vaccine will provide protection, nor is there evidence that the vaccine prevents transmission of SARS-CoV-2 from person to person.”
President Trump announced this as a “medical miracle” and vaccines would be available within 24 hours. [1, 2]
The rush to market was the result of President Trumps‘ Operation Warp Speed, where he allocated “$14 billion to accelerate vaccine development and to manufacture all of the top candidates in advance”.
- 11 Dec 2020 – EUA* for Pfizer CV19 vax – 30ug/dose
- 18 Dec 2020 – EUA for Moderna CV19 vax [5] – 100ug/dose
*EUA for an unapproved product
Under EUA these new products referred to as ‘vaccines’ are still undergoing data collection and thus are experimental. American frontline doctors have raised many concerns in a white paper, which includes:
- No vaccine based on messenger RNA (mRNA) has ever been approved for any disease, or even entered final-stage trials until now, so there’s no peer-reviewed published human data to compare how mRNA stacks up against older technologies.
- Previous coronavirus vaccine projects triggered re-challenge immune responses so strong that the test animals died, and the vaccine trials were halted. Scientists have never been able to create a successful coronavirus vaccine.
Is this new technology a “vaccine” or “medical device“?
The vaccines start rolling out across the US on Monday December 14, 2020, when early treatments are still suppressed.
Pfizer unblinds placebo control arm of trial group
On December 14, 2020 Pfizer/BioNTech removes the saline placebo control arm (unblinds) of their Phase 3 clinical trial, just 3 days after FDA issues Emergency Use Authorisation (EUA) for Pfizer-BioNTech COVID-19 vaccine. This unblinding of the control group by offering the trial participants the option to take the treatment product (the vaccine) eliminates the true ability to conduct legitimate long term safety studies.
- Dec 14, 2020 – Pfizer eliminates the placebo control clinical trial group
- Jan 14, 2021 – Moderna eliminates the placebo control clinical trial group
Under EUA these new products referred to as ‘vaccines’ are still undergoing data collection and thus are experimental. Placebo control safety data has now been compromised as the control group get the treatment. [1]
By March 2021 FOIA documents show 90% of placebo group had received at least one mRNA shot – i.e. “Pfizer stopped collecting useful data long before the planned end date of the clinical trial.”
Once a RCT is unblinded and the placebo control group is offered the treatment, the safety data is destroyed. “You cannot make conclusions from the data there in, after doing so.”
First COVID-19 vaccine administered in US
The first COVID-19 vaccine administered in America was to Sandra Lindsey, an ICU nurse, in New York City on December 14, 2020.
After months of vaccine development, two companies, Pfizer-BioNTech and Moderna applied to the FDA for Emergency Use Authorization (EUA). To receive approval, the companies’ data had to be reviewed by the Centers for Disease Control and Prevention (CDC) and its Advisory Committee on Immunization Practices (ACIP), which determined that health care workers and long-term care residents should be the first groups to receive the vaccine. [1, 2, 3, 4]
In a press release on December 10, 2020 the FDA assured the public that they would proceed “without sacrificing our rigorous scientific standards for safety and effectiveness.” “The FDA recognizes that transparency and dialogue are critical to building public confidence in COVID-19 vaccines.” “The FDA is considered the “gold standard” regulator of medical products. The process that the FDA uses to review is respected worldwide…”
On December 10, 2020 The FDA’s Center for Biologics Evaluation and Research’s Vaccines and Related Biological Products Advisory Committee (VRBPAC), “made up of independent scientific and public health experts from around the country”, met in open session to discuss the request for EUA of a “COVID-19 vaccine from Pfizer, Inc. in partnership with BioNTech Manufacturing GmbH” (Pfizer-BioNTech) “for the prevention of COVID-19 in individuals 16 years of age and older.” Which they approved on December 11, 2020..
ACIP met December 11& 13, 2020 “to review the Pfizer-BioNTech vaccine and recommended moving forward with its distribution to anyone over age 16. The FDA issued an EUA on Saturday 12th following the meeting and notified the CDC and Operation Warp Speed to coordinate distribution plans.”
On December 17, 2020 VRBPAC met again to discuss the EUA of the Moderna COVID-19 Vaccine “for the prevention of COVID-19 in individuals 18 years and older.” The following day on December 18, 2020 the FDA grants EUA to Moderna. [5]
Americans were assured by Operation Warp Speed that “Vaccines will help prevent the spread of COVID-19 and bring this pandemic to an end”
The CDC state that “Clinical trials provide data and information about how well a vaccine prevents an infectious disease and about how safe it is. The FDA evaluates these data, as well as manufacturing information, to assess the safety and effectiveness of vaccines. FDA then decides whether to approve a vaccine or authorize it for emergency use in the United States.”
WHO (finally) admints PCR tests cause false positives
Dated December 7, 2020, the WHO finally admits PCR tests cause false positive, and that it is a “predictive” tool to be used in conjunction with clinical signs and symptoms, in order to form a diagnosis..
After months of “user feedback” challenging PCR stand-alone validity, the WHO officially alerts the world of the issue of high PCR cycle thresholds (Ct) creating false positive cases.
The quality of the information from a PCR test drops as the Cycle threshold (Ct) increases, because there is less likely something there to be detected!
Using PCR on healthy people (no symptoms) give meaningless results. It does not prove infection, it does not prove an “asymptomatic carrier”. Yet this test has been used to determine a “case of COVID-19” which implies infection and being infectious and has led to lockdowns and the push for global vaccines.
Dr Anthony Fauci warned that Cycle thresholds (Ct) >37 is just detecting “dead nucleotides”, meaning not infectious virus. Many PCR tests for COVID-19 were set at Ct of 40-45 in 2020.
Experts have been highlighting this issue with the limitations of PCR for much of 2020.
This information around these tests has been suppressed.
UK Alpha Variant: SARS-CoV-2 variant has 17 spike protein mutations
On December 14, 2020, Matt Hancock informs UK Parliament of a new variant. The variant is referred to as SARS-CoV-2 VOC 202012/01 (Variant of Concern, year 2020, month 12, variant 01). [2]
The UK reported on December 21, 2020 that new SARS-CoV-2 variant had 17 mutations in the spike protein (23 overall), the target region for the COVID-19 vaccines and this may affect vaccine efficacy. [1, 3] The technical briefing stated “This is an unusually large number of mutations in a single cluster.”
By Jan 24, 2021 greater than 60 countries have detected this “UK variant” which has increased transmissibility.
In time this variant of concern (VOC) “variant 01” will be known as the Alpha variant.
Virus mutations and variants are monitored with genetic sequencing and tracked by GISAID. Depending on where and how much the virus mutates can affect its transmissibility, infectivity, vaccine effectiveness and whether it becomes a Variant of Concern.
The release of “The Lockdown Files” on March 1, 2023, revealed that health minister Matt Hancock secretly wanted to ‘frighten the pants off’ the public to ensure compliance with lockdown measures by deploying this “new variant” narrative. [4]
CDC has limited data on safety of COVID-19 vaccine for pregnancy
As of December 15, 2020 the CDC recommends “healthcare personnel who are pregnant” to discuss getting the COVID-19 vaccine “with a healthcare provider” as this “might help them make an informed decision”.
Currently there is “limited data about the safety of COVID-19 vaccines for people who are pregnant“, this population was excluded from clinical trails.
“While studies have not yet been done, based on how mRNA vaccines work [what about LNP], experts believe they are unlikely to pose a risk for people who are pregnant.”!!!
“Animal developmental and reproductive toxicity (DART) studies are ongoing and studies in people who are pregnant are planned. CDC and the Food and Drug Administration (FDA) have safety monitoring systems in place to capture information about vaccination during pregnancy and will closely monitor reports.”
Timeline pages:
1800s | 1900-1945 | 1946-1979 | 1980-1999 | 2000-2015 | 2016-2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025